SEC 13F Intelligence

Managers / Q3 2021 · view latest →

ISZO CAPITAL MANAGEMENT LP

CIK 0001607925 · 590 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022 · 646-775-4394

Reported Value
$227M
Q3 2021
Positions
7
Filings on Record
22
2019–present window
Filed
Nov 12, 2021
original filing

Summary

Iszo Capital Management LP reported $227M in U.S.-listed holdings across 7 positions for Q3 2021.

The portfolio is heavily concentrated: Nam Tai Ppty alone accounts for 60.4% of reported value.

Compared with Q2 2021, the fund opened 3 new positions and exited 4.

Portfolio Metrics

Turnover
+9.6%
vs prior filed quarter
Largest Position
+60.4%
Nam Tai Ppty
New / Exited
3 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $92MQ4 ’18Q1 ’19: $61MQ2 ’19: $64MQ3 ’19: $76MQ3 ’19Q4 ’19: $69MQ1 ’20: $65MQ2 ’20: $57MQ2 ’20Q3 ’20: $74MQ4 ’20: $96MQ1 ’21: $212MQ1 ’21Q2 ’21: $275MQ3 ’21: $227MQ4 ’21: $190MQ4 ’21Q1 ’22: $84MQ2 ’22: $64MQ3 ’22: $58MQ3 ’22Q4 ’22: $7MQ1 ’23: $19MQ2 ’23: $18MQ2 ’23Q3 ’23: $2MQ4 ’23: $2Mfilingsflow.com

Portfolio Composition

By security type
Other: 60.4%Common Stock: 39.3%ADR: 0.2%
  • Other · 60.4% · $137M
  • Common Stock · 39.3% · $89M
  • ADR · 0.2% · $506,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
LFCRLANDEC CORPNEW+1.65M1.65M+$15M$15M
CCELCRYO-CELL INTL INCNEW+496.5K496.5K+$6M$6M
MTBLYRENREN INCNEW+36.4K36.4K+$506,000$506,000
DMTKQDERMTECH INCSOLD OUT−1.09M0−$45M$0
ATEXANTERIX INCSOLD OUT−126.3K0−$8M$0
PTGXPROTAGONIST THERAPEUTICS INCSOLD OUT−93.9K0−$4M$0
CHICOS FAS INCSOLD OUT−20.7K0−$136,000$0
NOTVQINOTIV INCADDED+57.2K324.1K+$2M$9M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2021

7 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NAM TAI PPTY INCSHS60.43%$137M5.89M
2AVID BIOSERVICES INCCOM22.33%$51M2.35M
3LFCRLANDEC CORPhistory →COM6.71%$15M1.65M
4NOTVQINOTIV INChistory →COM4.18%$9M324.1K
5XPELXPEL INChistory →COM3.48%$8M103.9K
6CCELCRYO-CELL INTL INChistory →COM2.65%$6M496.5K
7MTBLYRENREN INCSPONSORED ADS0.22%$506,00036.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$2M1Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2M3Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$18M3Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$19M10May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$7M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$58M6Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$64M6Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$84M5May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$190M7Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$227M7Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$275M8Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$212M5May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$96M6Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$74M5Nov 17, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2020$57M10Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$65M10May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$69M3Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$76M4Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$64M2Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$61M5May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$92M5Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.